How are Medtronic awards related to the MMED RSU grants for MiniMed Group (MMED)?

The MMED restricted stock units came from converting certain Medtronic restricted stock and performance share awards. This conversion followed MiniMed’s separation from Medtronic and was carried out under an Employee Matters Agreement that governed how Medtronic equity awards became MMED equity.

MiniMed Group (MMED) converts Medtronic awards into new RSUs for officer

Q: What did MiniMed Group (MMED) disclose about Dianaty Ali’s Form 4 transactions?

MiniMed Group disclosed that officer Dianaty Ali received several grants of common stock on March 11, 2026. These were stock awards at $0.00 per share rather than open-market purchases, reflecting equity compensation rather than trading activity.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

MiniMed Group, Inc. reported that officer Dianaty Ali received multiple grants of common stock on March 11, 2026, all with a grant price of $0.00 per share. These are classified as awards rather than open-market purchases.

The grants represent MMED restricted stock units created when prior Medtronic restricted and performance share awards were converted following MiniMed’s separation from Medtronic effective March 9, 2026, under an Employee Matters Agreement. The MMED RSUs were issued under the 2026 MiniMed Group, Inc. Long Term Incentive Plan and vest on several dates between July 31, 2026 and October 29, 2028, including single-date vesting and a three-installment schedule.

Insider Trade Summary

8 transactions reported

Mixed 8 txns

Insider Dianaty Ali

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	11,054	$0.00	--
Grant/Award	Common Stock	46,989	$0.00	--
Grant/Award	Common Stock	35,448	$0.00	--
Grant/Award	Common Stock	14,628	$0.00	--
Grant/Award	Common Stock	33,684	$0.00	--
Grant/Award	Common Stock	35,448	$0.00	--
Grant/Award	Common Stock	11,563	$0.00	--
Grant/Award	Common Stock	2,444	$0.00	--

Holdings After Transaction: Common Stock — 11,054 shares (Direct)

Footnotes (1)

In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest on December 6, 2026. Includes shares to be issued in connection with the vesting of one or more restricted stock units. Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 30, 2027. Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 28, 2028. Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 31, 2026. Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 29, 2027. Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028. Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on December 6, 2026. Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest in three equal installments on October 28, 2026, October 28, 2027 and October 29, 2028.

Form 4 Insider Transactions: What Each Field Means →

03/13/2026 - 07:25 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dianaty Ali

(Last)

(First)

(Middle)

C/O 18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE

91325

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/11/2026⁽¹⁾⁽²⁾		A		11,054⁽³⁾	A	⁽³⁾	11,054⁽⁴⁾	D
Common Stock	03/11/2026⁽¹⁾⁽²⁾		A		46,989⁽⁵⁾	A	⁽⁵⁾	46,989⁽⁴⁾	D
Common Stock	03/11/2026⁽¹⁾⁽²⁾		A		35,448⁽⁶⁾	A	⁽⁶⁾	35,448⁽⁴⁾	D
Common Stock	03/11/2026⁽¹⁾⁽²⁾		A		14,628⁽⁷⁾	A	⁽⁷⁾	14,628⁽⁴⁾	D
Common Stock	03/11/2026⁽¹⁾⁽²⁾		A		33,684⁽⁸⁾	A	⁽⁸⁾	33,684⁽⁴⁾	D
Common Stock	03/11/2026⁽¹⁾⁽²⁾		A		35,448⁽⁹⁾	A	⁽⁹⁾	35,448⁽⁴⁾	D
Common Stock	03/11/2026⁽¹⁾⁽²⁾		A		11,563⁽¹⁰⁾	A	⁽¹⁰⁾	11,563⁽⁴⁾	D
Common Stock	03/11/2026⁽¹⁾⁽²⁾		A		2,444⁽¹¹⁾	A	⁽¹¹⁾	2,444⁽⁴⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA").

2. Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion").

3. Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest on December 6, 2026.

4. Includes shares to be issued in connection with the vesting of one or more restricted stock units.

5. Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 30, 2027.

6. Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 28, 2028.

7. Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 31, 2026.

8. Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 29, 2027.

9. Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028.

10. Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on December 6, 2026.

11. Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest in three equal installments on October 28, 2026, October 28, 2027 and October 29, 2028.

Remarks:

EVP, Chief Product & Technology Officer

	/s/ Bryan F. Kelly, attorney-in-fact	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did MiniMed Group (MMED) disclose about Dianaty Ali’s Form 4 transactions?

MiniMed Group disclosed that officer Dianaty Ali received several grants of common stock on March 11, 2026. These were stock awards at $0.00 per share rather than open-market purchases, reflecting equity compensation rather than trading activity.

Under what plan were the MMED RSUs granted to Dianaty Ali at MiniMed Group (MMED)?

The MMED restricted stock units granted to Dianaty Ali were issued under the 2026 MiniMed Group, Inc. Long Term Incentive Plan. This plan provides equity-based compensation, and the converted awards now reference MiniMed common stock instead of Medtronic shares.

When do Dianaty Ali’s MMED RSUs at MiniMed Group vest?

The MMED RSUs vest on several future dates, including December 6, 2026, April 30, 2027, April 28, 2028, July 31, 2026, July 29, 2027, July 28, 2028, and in three installments on October 28, 2026, October 28, 2027, and October 29, 2028.

What is the Equity Award Conversion mentioned in the MiniMed Group (MMED) Form 4 footnotes?

The Equity Award Conversion refers to the process that turned Medtronic equity awards into MMED restricted stock units. It used average closing trading prices for Medtronic and MMED shares around early March 2026 to determine how many MMED RSUs replaced each original Medtronic award.

Does Dianaty Ali’s Form 4 for MiniMed Group (MMED) involve any stock sales?

The Form 4 only shows acquisition-type transactions coded as grants or awards, with no sales reported. All entries are classified as awards of MMED common stock or RSUs, indicating compensation-related grants instead of open-market selling activity.